Junrong Zou

1.1k total citations
53 papers, 769 citations indexed

About

Junrong Zou is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Junrong Zou has authored 53 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 14 papers in Cancer Research and 11 papers in Surgery. Recurrent topics in Junrong Zou's work include Metabolism, Diabetes, and Cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (5 papers). Junrong Zou is often cited by papers focused on Metabolism, Diabetes, and Cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (5 papers). Junrong Zou collaborates with scholars based in China, United States and United Kingdom. Junrong Zou's co-authors include Deqiang Huang, Xiaofeng Zou, Zhijun Luo, Guoxi Zhang, Ying Ying, Nonghua Lv, Rong Ke, Yunfei Luo, Ruipu Sun and Shanshan Jiang and has published in prestigious journals such as Nature Communications, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Junrong Zou

49 papers receiving 763 citations

Peers

Junrong Zou

ONCOL

PRM

SURGE

Tian‐Huei Chu Taiwan

Brendan D. Looyenga United States

Zhiyuan Fan China

Sang Bum Kim United States

Shiori Mori Japan

Xinsheng Wang China

Seong Hye Park South Korea

Imoh S. Okon United States

Yoo Jin Na South Korea

Tian‐Huei Chu Taiwan

Junrong Zou

348 ×0.8

172 ×0.9

132 ×1.1

ONCOL

59 ×0.6

PRM

84 ×1.1

SURGE

Citations per year, relative to Junrong Zou Junrong Zou (= 1×) peers Tian‐Huei Chu

Countries citing papers authored by Junrong Zou

Since Specialization

Citations

This map shows the geographic impact of Junrong Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junrong Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junrong Zou more than expected).

Fields of papers citing papers by Junrong Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junrong Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junrong Zou. The network helps show where Junrong Zou may publish in the future.

Co-authorship network of co-authors of Junrong Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Junrong Zou. A scholar is included among the top collaborators of Junrong Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junrong Zou. Junrong Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zou, Junrong, et al.. (2025). Recurrence and prevention strategies for non-muscle-invasive bladder cancer: A comprehensive review. Asian journal of urology. 13(1). 11–23. 1 indexed citations

Zou, Junrong, et al.. (2025). AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer. Frontiers in Oncology. 15. 1520808–1520808. 2 indexed citations

Dong, Wen, et al.. (2025). The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker. Frontiers in Oncology. 15. 1622117–1622117.

Zeng, Zhili, et al.. (2025). Progress of mesenchymal stem cells affecting extracellular matrix metabolism in the treatment of female stress urinary incontinence. Stem Cell Research & Therapy. 16(1). 95–95. 3 indexed citations

Chen, Tao, et al.. (2024). Calcium sensing receptor regulate claudin-14 via PKA-STAT3 pathway in rat model of nephrolithiasis. Frontiers in Pharmacology. 15. 1477122–1477122. 2 indexed citations

Jiang, Bo, Gang Xu, Wei Xia, et al.. (2024). Overexpression of DUSP26 gene suppressed the proliferation, migration, and invasion of human prostate cancer cells. Experimental Cell Research. 442(2). 114231–114231.

Zou, Junrong, et al.. (2024). Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: A clinicopathological study. World Journal of Gastrointestinal Oncology. 16(1). 118–132. 2 indexed citations

Chen, Tao, et al.. (2024). Crosstalk between m6A modification and autophagy in cancer. Cell & Bioscience. 14(1). 44–44. 9 indexed citations

Jin, Jiajia, et al.. (2023). Emerging applications of extracellular vesicles in tumor therapy. Cancer Nanotechnology. 14(1). 4 indexed citations

10.

Luo, Hui, et al.. (2023). Autonomic Nervous System Dysfunction Is Related to Chronic Prostatitis/Chronic Pelvic Pain Syndrome. The World Journal of Men s Health. 42(1). 1–1. 17 indexed citations

11.

Zou, Yuhua, et al.. (2023). Giant superficial angiomyxoma of the male perineum: A case report. Frontiers in Surgery. 9. 1010050–1010050. 1 indexed citations

12.

Luo, Hui, Hui Xu, Biao Qian, et al.. (2023). Preclinical models and evaluation criteria of prostatitis. Frontiers in Immunology. 14. 1183895–1183895. 9 indexed citations

13.

Jiang, Shanshan, Junrong Zou, Jianyu Dong, et al.. (2023). Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC. Cell Communication and Signaling. 21(1). 9–9. 12 indexed citations

14.

Peng, Peng, Junrong Zou, Bin Zhong, et al.. (2022). Protective Effects and Mechanisms of Flavonoids in Renal Ischemia-Reperfusion Injury. Pharmacology. 108(1). 27–36. 25 indexed citations

15.

Zhang, Guoxi, et al.. (2022). Prevention and Treatment of Side Effects of Immunotherapy for Bladder Cancer. Frontiers in Oncology. 12. 879391–879391. 8 indexed citations

16.

Jie, Zhigang, et al.. (2022). Overexpression of SATB1 correlates with epithelial-mesenchymal transition and lymphatic metastasis in gastric cancer. Annals of Diagnostic Pathology. 62. 152074–152074. 1 indexed citations

17.

Zhang, Guoxi, Junrong Zou, Biao Qian, et al.. (2021). Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells. Cell Death and Disease. 12(11). 1067–1067. 7 indexed citations

18.

Jiang, Shanshan, Yunfei Luo, Zhan Zhan, et al.. (2021). AMP-activated protein kinase re-sensitizes A549 to paclitaxel via up-regulating solute carrier organic anion transporter family member 1B3 expression. Cellular Signalling. 91. 110215–110215. 6 indexed citations

19.

Li, Nianshuang, Junrong Zou, Hui Lin, et al.. (2015). LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells. Tumor Biology. 37(6). 8249–8258. 48 indexed citations

20.

Zou, Junrong, et al.. (2015). Lipopolysaccharide-induced tumor necrosis factor-α factor enhances inflammation and is associated with cancer (Review). Molecular Medicine Reports. 12(5). 6399–6404. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact